GABA, bicuculline and central inhibition.
D000409:Alanine / Q000037:antagonists & inhibitors; D000470:Alkaloids / Q000494:pharmacology*; D000613:Aminobutyrates / Q000037:antagonists & inhibitors*; D000818:Animals; D002415:Cats; D002490:Central Nervous System / Q000502:physiology*; D002540:Cerebral Cortex / Q000502:physiology; D004336:Drug Antagonism; D005998:Glycine / Q000037:antagonists & inhibitors; D007395:Interneurons / Q000502:physiology; D007546:Isoquinolines / Q000494:pharmacology*; D018377:Neurotransmitter Agents / Q000502:physiology*; D011689:Purkinje Cells / Q000502:physiology; D011955:Receptors, Drug; D013116:Spinal Cord / Q000502:physiology; D013331:Strychnine / Q000494:pharmacology; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects*
D000470:Alkaloids; D000613:Aminobutyrates; D007546:Isoquinolines; D018377:Neurotransmitter Agents; D011955:Receptors, Drug; D013331:Strychnine; D000409:Alanine; D005998:Glycine